Unplanned pregnancy and contraceptive use in women attending drug treatment services

Aust N Z J Obstet Gynaecol. 2012 Apr;52(2):146-50. doi: 10.1111/j.1479-828X.2012.01413.x. Epub 2012 Feb 15.

Abstract

Background: At an international level, there are calls for a greater focus on women and harm reduction in recognition that female drug users have a unique set of issues that are not routinely assessed in drug treatment programs.

Aims: To assess the pregnancy history, current pregnancy risk and contraceptive use of nonpregnant women attending opioid treatment programs (OTPs).

Methods: This study involved a structured questionnaire survey of 204 women attending outpatient OTP services within the Sydney South West Area Health Service.

Results: Two hundred and four women of 302 (67.5%) enroled in OTPs at the time completed surveys. Key findings were high pregnancy rates, with 28.9% of women reporting six or more pregnancies, high rates of adverse pregnancy outcomes (miscarriage, termination and stillbirth) compared with national data and poor uptake of contraception, with only 54.7% of sexually active women not wanting to get pregnant using a method. Women expressed diverse preferences for the type and location of women's health services they felt would meet their needs.

Conclusion: Women in OTP clinics have unaddressed reproductive health issues, particularly around contraception. Addressing these will potentially minimise the risk of material deprivation and social exclusion in these women and improve their well-being through greater control and choice over their fertility. Current women's health service provision in OTP programs involves referral to external services, but an integrated model of care may best address the unmet contraceptive needs of these women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Buprenorphine / therapeutic use
  • Contraception Behavior / statistics & numerical data*
  • Delivery of Health Care, Integrated / statistics & numerical data
  • Drug Users / statistics & numerical data*
  • Female
  • Health Surveys / statistics & numerical data*
  • Humans
  • Methadone / therapeutic use
  • Middle Aged
  • Opiate Substitution Treatment
  • Pregnancy
  • Pregnancy Outcome / epidemiology*
  • Pregnancy, Unplanned*
  • Surveys and Questionnaires
  • Women's Health Services / statistics & numerical data
  • Young Adult

Substances

  • Buprenorphine
  • Methadone